SXC

bromo(4-{3-[(R)-ethoxy(4-nitrophenoxy)phosphoryl]propyl}-2,6-bis[(methylsulfanyl-kappaS)methyl]phenyl-kappaC~1~)palladium(2+)

Created:	2008-10-08
Last modified:	2024-09-27

Find Related PDB Entry
2 entries where SXC is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	2
Atom Count	59
Chiral Atom Count	4
Bond Count	62
Aromatic Bond Count	12

2D diagram of SXC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	bromo(4-{3-[(R)-ethoxy(4-nitrophenoxy)phosphoryl]propyl}-2,6-bis[(methylsulfanyl-kappaS)methyl]phenyl-kappaC~1~)palladium(2+)
Synonyms	ethyl 4-nitrophenyl P-[3-(4-(bromopallado)-1,3-bis[(methylthio)methyl]-phenyl)propyl]phosphonate
Systematic Name (OpenEye OEToolkits)	n/a
Formula	C₂₁ H₂₇ Br N O₅ P Pd S₂
Molecular Weight	654.871
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	[O-][N+](=O)c4ccc(OP(=O)(OCC)CCCc1cc2c3c(c1)C[S+](C)[Pd]3(Br)[S+](C2)C)cc4
SMILES	CACTVS	3.341	CCO[P](=O)(CCCc1cc2C[S+](C)[Pd]3(Br)[S+](C)Cc(c1)c23)Oc4ccc(cc4)[N+]([O-])=O
SMILES	OpenEye OEToolkits	1.5.0	CCOP(=O)(CCCc1cc2c3c(c1)C[S+]([Pd]3([S+](C2)C)Br)C)Oc4ccc(cc4)[N+](=O)[O-]
Canonical SMILES	CACTVS	3.341	CCO[P@](=O)(CCCc1cc2C[S@@+](C)[Pd@@]3(Br)[S@+](C)Cc(c1)c23)Oc4ccc(cc4)[N+]([O-])=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	CCO[P@](=O)(CCCc1cc2c3c(c1)C[S@+]([Pd]3([S@@+](C2)C)Br)C)Oc4ccc(cc4)[N+](=O)[O-]
InChI	InChI	1.03	InChI=1S/C21H27NO5PS2.BrH.Pd/c1-4-26-28(25,27-21-9-7-20(8-10-21)22(23)24)11-5-6-17-12-18(15-29-2)14-19(13-17)16-30-3;;/h7-10,12-13H,4-6,11,15-16H2,1-3H3;1H;/q;;+3/p-1/t28-;;/m1../s1
InChIKey	InChI	1.03	UQJAYMPWLMSAFV-QDSLRZTOSA-M

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.